Nanophotonics has emerged as a transformative field that is offering innovative solutions at the intersection of nanotechnology and photonics. This cutting-edge technology involves the manipulation of light at the nanoscale, enabling precise control over the interaction between light and matter. In the realm of pharmaceuticals, nanophotonics holds significant promise for drug delivery, diagnostics, and therapeutic interventions. The use of nanophotonic materials, such as plasmonic nanoparticles, allows for enhanced imaging modalities and targeted drug delivery systems. These nano-sized structures can be engineered to interact with specific biological targets, providing unprecedented accuracy in drug distribution and minimizing side effects.
Additionally, nanophotonics facilitates the development of advanced biosensors for real-time monitoring of biochemical processes, enabling personalized medicine approaches. As the pharmaceutical industry continues to explore the potential of nanophotonics, the convergence of these fields is poised to revolutionize drug development and healthcare, paving the way for more effective and tailored therapeutic interventions.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico